ESPR
NASDAQ · Pharmaceuticals
Esperion Therapeutics Inc
$2.55
-0.05 (-1.92%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+641.6% upside
Low Target
$12.50
Average Target
$18.91
High Target
$21.23
Current Price
$2.55
Current
$2.55
$2.55
Target
$18.91
$18.91
$12.50
$18.91 avg
$21.23
Scenario Analysis
Bear Case
$12.50
390.2%
Low target
Base Case
$18.91
+641.6%
Avg target
Bull Case
$21.23
+732.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$4.18
-38.9% from high
52-Week Low
$0.69
+268.2% from low
Target vs 52W High
$18.91
+352.9% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |